Mr. Maurer brings a diverse set of business and legal skills to Heron Capital. Mr. Maurer concentrates on medical devices, and leads the firm's efforts for cardiovascular investments. Prior to forming the Fund, Mr. Maurer worked as a corporate attorney at Schiff Hardin, L.L.P. in Chicago, Illinois, concentrating on mergers and acquisitions, venture finance and other financing transactions, and private placements. Mr. Maurer also worked for The National Bank of Indianapolis, where he managed the bank's real estate and branch expansion activities. Mr. Maurer also co-managed privately-held real estate investments in Indianapolis. Mr. Maurer received his J.D. from Washington University in St. Louis, Missouri and his B.S. in Finance and International Business from Indiana University.

Mr. Maurer currently represents Heron Capital as a Director on the Board of NeoChord, Inc. and as a board observer on IDev Technologies, Inc.

  Download vCard

Mr. Etzkorn brings over eight years of venture capital experience and more than a decade of operational and technical management experience to the Fund. Prior to joining Heron, Mr. Etzkorn was a Principal at CID Capital, a life science and technology venture fund. While at CID, his portfolio responsibilities included: Axiomed Spine Corporation, Bridge Semiconductor Corporation, EKOS Corporation, HyperNex, Inc. (acquired by Nova Measuring Instruments) and Renal Solutions, Inc. (acquired by Fresenius Medical Care).

Prior to joining CID Capital in 2001, Mr. Etzkorn spent thirteen years in the U.S. Navy in a variety of technical and supervisory roles, most recently as a Nuclear Engineer and Communications Officer aboard the Fleet Ballistic Missile Submarine USS ALASKA, where he was responsible for the establishment and management of its Information Technology Department. He also served as an Assistant Professor in the Department of Naval Science at the University of Illinois. Mr. Etzkorn has served as an advisor to the National Science Foundation for the Small Business Innovation Research (SBIR) Program and as an advisory board member for the Telemark Group, a New York based investment fund. He received his M.B.A. from the University of Illinois and a bachelor's degree in Electrical and Computer Engineering from the University of Wisconsin.

Currently, Mr. Etzkorn serves as a Director on the Board of AirXpanders and Celleration and is a board observer for BioSET, Inc.  He also led the firm's investment in Atlantis Components, Inc. which was sold to Astra Tech AB, a subsidiary of AstraZeneca, in 2007.

Download vCard

Ms. Rothschild received her B.A. from Tulane University, and both her M.B.A. and M.H.A. from Indiana University. Prior to joining the Fund, Ms. Rothschild was Manager of Product Design and Development with Humana, Inc., one of the nation's largest health benefits companies. Ms. Rothschild's diverse prior experience includes strategic advisor for McKesson HBOC; designing and managing large payer and venture financed healthcare IT initiatives at RealMed; executive level education at Indiana University; and consulting with Caduceus Partners. Ms. Rothschild offers a diverse healthcare and business background to the Fund.